"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”
A study looking in detail at prostate cancer genes (PROGENY)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking in detail at the genes of prostate cancer cells.
More about this trial
We don’t fully understand
- How prostate cancer develops
- Why some cancers spread and others don’t
- Why some prostate cancers respond to treatment and others don’t
The study team want to take a number of samples of tissue (
The aim is to find out if the differences in the genes can help answer these questions.
Please note it is very unlikely that you would get any direct benefit from taking part in this study, nor will it affect any treatment you have. The findings may help men with prostate cancer in the future.
Who can enter
You may be able to enter this trial if
You cannot enter this trial if you
This study will recruit about 200 men who are going to have a template biopsy of their prostate.
The study team will ask for up to 6 extra pieces of tissue to be taken when you have your biopsy. They will also ask for some blood samples.
They will use these samples to look at the genetic material in the prostate cancer cells. They will compare it with the normal genetic material in your blood.
There are no extra visits to the hospital if you agree to take part in this study.
The most common side effects of having a template biopsy of the prostate gland are
- Pain or discomfort
- Burning sensation when passing urine
- Blood in your urine
- Blood in your semen
- Difficulty getting a full erection
These will get better. Your doctor can tell you how long it may take.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Hashim Ahmed
NIHR Clinical Research Network: Cancer
Prostate Cancer Foundation
University College London (UCL)